Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10897288 | Cancer Epidemiology | 2015 | 7 Pages |
Abstract
Developing countries, with poorer quality data and a high historical burden of hepatitis, were predicted to have the majority of missed HCC cases in 2012 based on our model. These countries are, therefore, less able to detect, budget for or manage HCC. The high cost of HCC treatment, as well as its economic implications, poses a challenge in resource poor settings.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
K. Sartorius, B. Sartorius, C. Aldous, P.S. Govender, T.E. Madiba,